An USPTO patent has been granted to Regulus Therapeutics Inc., a biopharmaceutical company which leads the discovery and development of innovative medicines targeting microRNAs (miR) on 12 November 2015. The patent is related to Regulus' most advanced two microRNA therapeutics, RG-101(GalNAc-conjugated anti-miR-122 being developed to treat HCV...

Almac Discovery, a research driven oncology company that is dedicated to the discovery and development of novel and innovative approaches to the treatment of cancer, has announced that it has been granted patent protection (Patent Number 2040728) for its novel therapeutic drug, ALM201, in Europe, one of the largest Biopharmaceutical markets in the world. This...

A recently published report in Azonano.com dated 13th September 2015, states development of a breakthrough device that can significantly reduce the cost of sophisticated lab tests for medical disorders and diseases and glorified credit goes to engineers from Rutgers School of Engineering, New Jersey. As proposed, the medical device could reduce cost of sophisticated tests...

It was on August 20, 2015, that Caprotec Bioanalytics, GmbH proclaimed issue of patent by United States Patent Office (No. US 9,034,789) entitled “Capture Compounds, Collections Thereof and Methods for Analyzing the Proteome and Complex Compositions” on ground-breaking Capture Compound Mass Spectrometry (CCMS) technology. Caprotec, founded in 2007 by serial entrepreneur Prof. Hubert Koester is...